Lecturer: Andre Altmann (UCL CMIC)
In this talk I will speak about imaging genetics and its application to brain disorders. In imaging genetics measures derived from (neuro-)imaging are used as endpoints in statistical analyses of genetic data. This is in contrast to conducting such studies with dichotomous case-control labels. Replacing crisp diagnostic labels with imaging marker that are thought to better reflect the disease process are expected to lend increased statistical power to such analyses and also allow us to investigate different aspects of the underlying disease process such as disease progression speed or the emergence of distinct sub-types.
